InvestorsHub Logo
Followers 179
Posts 35357
Boards Moderated 20
Alias Born 04/17/2013

Re: janice shell post# 118092

Tuesday, 02/21/2017 1:16:18 AM

Tuesday, February 21, 2017 1:16:18 AM

Post# of 220812
Welp, no legit company is gonna buy Thanatos and no sane or even partially-insane investor is gonna pump another nickel into that jukebox. So, the only way I can see for Lizzy 'Borden' Holmes and idiots like Tim Draper to gett back subpennys on the megadollar is to RM the turd into a pennyshell, cutt expenses to near zero, and print and dump endless reams of stock to the lowest common victim class - the pennyvestors who believe in unicorns and swallow lies like Dean Martin swallowed martinis. One must admit that Lizzy is a charismatic leader-like persona that, in finest Jim Jones style, can lead the herd of pennystock cargo cultists over the cliff over-and-over-and-over, drain them of every penny - or 0.0001 penny - then blame the 'naked shorts'.

With the current square footage rate for wet lab/office space in PA, the only presence Thanatos will be able to afford is a P.O. box - and there's a several month waiting list for those - even the smallest box type. So I'd recommend that Lizzy relo 'the headquarters' to Bombay Beach on the Salton Sea. That also reduces her run distance to the Mexican border when the criminal charges hitt and the popo come to scoop her up. Fairly straight shott through Brawley, Octillo Wells, Calexico, then TacoLand.

I always laff at financial projections and 'models' of start-ups with zero operating experience selling the 'product(s)' they tout. I cannot bleeve that anybuddy, lett alone MBAs and CPAs, give that 'modeling' shit ANY credence whatsoever (butt in fact they do!).

Even so, Thanatos seems to have slightly missed their projections, coming in with a solid ZERO revenue for 2015 and 2016. Oops!

"Theranos’s wild revenue projections. While soliciting money in recent years, the Palo Alto–based company had predicted revenue of almost $2 billion and net income of $505 million in 2016. Theranos had expected its revenue to be nearly $1 billion in 2015, with a net income of about $330 million, meaning that Theranos expected to double its earnings over the course of a year, despite little evidence that its tests worked at the time it was soliciting funding. These figures no doubt helped Holmes attract a slew of primarily non-traditional, non-tech investors, raising more than $686 million at a $9 billion valuation. But like the accuracy of its diagnostic tool, the success of Theranos’s revenue projections was apparently also not a guarantee."


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.